Back to Search
RICHARD SAMUEL FINN MD
MD
Hematology & Oncology Physician
NPI: 1811912074IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A67544(CA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A67544(CA)
Education
UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
PMID 19374603·Expert Rev Anticancer Ther·2009
6-review
Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.
PMID 18482274·Liver Int·2009
4-observational
Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatment in HER2-negative or unknown metastatic breast cancer.
PMID 19620495·J Clin Oncol·2009
2-rct
Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway.
PMID 18778245·Biochem J·2009
7-preclinical
Identifying protein domains with the Pfam database.
PMID 18819075·Curr Protoc Bioinformatics·2008
8-other
sNASP, a histone H1-specific eukaryotic chaperone dimer that facilitates chromatin assembly.
PMID 18456819·Biophys J·2008
7-preclinical
Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.
PMID 18805792·J Biol Chem·2008
7-preclinical
Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system.
PMID 17435107·J Pharmacol Exp Ther·2007
7-preclinical
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.
PMID 17268817·Breast Cancer Res Treat·2007
8-other
Rainbow tags: a visual tag system for recombinant protein expression and purification.
PMID 15789482·Biotechniques·2005
7-preclinical
Identification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1.
PMID 15900210·Pharmacogenet Genomics·2005
8-other
iPfam: visualization of protein-protein interactions in PDB at domain and amino acid resolutions.
PMID 15353450·Bioinformatics·2005
8-other
Identifying protein domains with the Pfam database.
PMID 18428696·Curr Protoc Bioinformatics·2003
8-other
Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1.
PMID 12631275·Eur J Biochem·2003
8-other
Monoclonal antibody therapy for breast cancer: herceptin.
PMID 15338747·Cancer Chemother Biol Response Modif·2003
6-review
Evolution and differential expression of a vertebrate vitellogenin gene cluster.
PMID 19123940·BMC Evol Biol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 15503 VENTURA BLVD STE 150
ENCINO, CA 91436 - Phone
- (818) 995-8044
Locations (4)
Practice Location
15503 VENTURA BLVD STE 150, ENCINO, CA
(818) 995-8044
Practice Location
200 UCLA MEDICAL PLZ STE 214, LOS ANGELES, CA
(310) 794-7788
Practice Location
2020 SANTA MONICA BLVD STE 600, SANTA MONICA, CA
(310) 829-5471
Practice Location
2336 SANTA MONICA BLVD STE 301, SANTA MONICA, CA
(310) 829-5471
Quick Facts
- NPI
- 1811912074
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 4
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile